Log in to save to my catalogue

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPT...

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPT...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4be70ce338214ab0a34f240e9ededde1

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Broadly neutralizing antibodies (bnAbs) are a promising approach for HIV-1 prevention. In the Antibody Mediated Prevention (AMP) trials, a CD4-binding site targeting bnAb, VRC01, administered intravenously (IV), demonstrated 75% prevention efficacy against highly neutralization-sensitive viruses but was ineffective against less sensitive viruses. V...

Alternative Titles

Full title

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4be70ce338214ab0a34f240e9ededde1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4be70ce338214ab0a34f240e9ededde1

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1004329

How to access this item